1919 Investment Counsel’s Novartis NVS Stock Holding History

1919 Investment Counsel’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.49M	Buy	17,641 +3,895	+28%	+$315K	0.03%	334
2014 Q2	$1.12M	Buy	13,746 +2,810	+26%	+$221K	0.02%	371
2014 Q1	$834K	Sell	10,936 -647	-6%	-$47.1K	0.02%	397
2013 Q4	$835K	Sell	11,583 -45	-0.4%	-$3.13K	0.02%	396
2013 Q3	$800K	Sell	11,628 -519	-4%	-$34.3K	0.02%	392
2013 Q2	$770K	Buy	+12,147	New	+$790K	0.02%	383

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

1919 Investment Counsel's NVS Position: Q3 2014 in Review

1919 Investment Counsel increased its Novartis (NVS) stake by 28% in Q3 2014, buying an estimated $315K and bringing the position to 17,641 shares worth $1.49M. The position accounts for 0.03% of the portfolio, ranked #334.

1919 Investment Counsel first reported a position in NVS in Q2 2013 and has held it in 6 quarters since. 875 funds tracked by Wall St. Rank hold NVS as of Q3 2014.

1919 Investment Counsel held 17,641 shares of Novartis worth $1.49M as of Q3 2014.
1919 Investment Counsel bought 3,895 Novartis shares in Q3 2014, an estimated $315K.
Novartis made up 0.03% of 1919 Investment Counsel's portfolio in Q3 2014, its #334 holding.
1919 Investment Counsel first reported a position in Novartis in Q2 2013 and has held it in 6 quarters since.
875 funds tracked by Wall St. Rank held Novartis as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.